All In MedTech

Device Trial Radar · NCT07277946

AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE

Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

May 14, 2026

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
TissiumNot on our public-company list
Sponsor type
Industry
First posted
Dec 11, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this clinical trial is to assess the safety and performance of the ECLIPSIUM device in securing mesh during ventral hernia repair. The study will evaluate whether ECLIPSIUM, a bioresorbable polymer-based fixation device, is effective in reducing the risk of hernia recurrence when compared with bioresorbable tacks. This information will support understanding of ECLIPSIUM's potential clinical benefits in ventral hernia repair.

Conditions

  • Hernia

Interventions

  • ECLIPSIUM® SystemDevice

    The ECLIPSIUM® System functions by applying a biodegradable, implantable polymer coating to the prosthetic material under guidance of a template to ensure appropriate application, followed by in situ photo-activation using the TISSIUM curing light to secure the mesh to the abdominal wall.

  • Resorbable tacks (AbsorbaTack/SorbaFix)Device

    Resorbable tacks are surgical fasteners used to secure a hernia mesh in place. Resorbable tacks are designed to be absorbed by the body over time, gradually losing strength as the tissue ingrowth into the mesh occurs and takes over the support function.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hernia Recurrence at 6 monthsTime frame: 6 months
  2. Cumulative Incidence of ComplicationsTime frame: 12 months

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • VA Loma Linda

    Loma Linda, California · Not yet recruiting

  • University of Florida Health

    Gainesville, Florida · Not yet recruiting

  • Northwestern University - Feinberg School of Medicine

    Chicago, Illinois · Recruiting

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.